BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Return 108.35%
This Quarter Return
-6.36%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.58B
AUM Growth
-$367M
Cap. Flow
-$12.5M
Cap. Flow %
-0.79%
Top 10 Hldgs %
42.1%
Holding
79
New
5
Increased
1
Reduced
2
Closed
3

Top Buys

1
SRPT icon
Sarepta Therapeutics
SRPT
$15M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$12.8M
3
ASND icon
Ascendis Pharma
ASND
$6.51M
4
ETNB icon
89bio
ETNB
$4.51M
5
COGT icon
Cogent Biosciences
COGT
$3.83M

Top Sells

1
ITOS
iTeos Therapeutics
ITOS
$21.4M
2
XBI icon
SPDR S&P Biotech ETF
XBI
$14.9M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
$14.5M
4
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
$5.55M
5
GNCA
Genocea Biosciences, Inc.
GNCA
$1.42M

Sector Composition

1 Healthcare 96.9%
2 Financials 0.75%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IOVA icon
26
Iovance Biotherapeutics
IOVA
$792M
$21.4M 1.35%
1,935,133
– –
DAWN icon
27
Day One Biopharmaceuticals
DAWN
$753M
$21.3M 1.35%
1,189,943
– –
GOSS icon
28
Gossamer Bio
GOSS
$568M
$20.6M 1.31%
2,462,358
– –
RCKT icon
29
Rocket Pharmaceuticals
RCKT
$344M
$20.2M 1.28%
1,466,051
– –
XENE icon
30
Xenon Pharmaceuticals
XENE
$2.97B
$18.3M 1.16%
600,000
– –
ACAD icon
31
Acadia Pharmaceuticals
ACAD
$4.32B
$17.8M 1.13%
1,263,930
– –
PNT
32
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$17M 1.08%
2,500,000
– –
NUVL icon
33
Nuvalent
NUVL
$5.72B
$16.4M 1.04%
1,210,192
– –
RNA icon
34
Avidity Biosciences
RNA
$6.19B
$16.3M 1.03%
1,121,327
– –
NRIX icon
35
Nurix Therapeutics
NRIX
$699M
$15.5M 0.98%
1,224,892
– –
SRPT icon
36
Sarepta Therapeutics
SRPT
$1.94B
$15M 0.95%
+200,000
New +$15M
BMEA icon
37
Biomea Fusion
BMEA
$108M
$14.2M 0.9%
1,188,405
– –
NUVB icon
38
Nuvation Bio
NUVB
$1.16B
$14.1M 0.89%
4,341,009
– –
CGEM icon
39
Cullinan Oncology
CGEM
$407M
$13.8M 0.87%
1,074,082
– –
MIST icon
40
Milestone Pharmaceuticals
MIST
$150M
$13.8M 0.87%
2,238,861
– –
FATE icon
41
Fate Therapeutics
FATE
$113M
$12.4M 0.78%
500,000
– –
GHRS icon
42
GH Research
GHRS
$870M
$10.1M 0.64%
1,013,399
– –
PRTA icon
43
Prothena Corp
PRTA
$441M
$8.15M 0.52%
300,000
– –
AKRO icon
44
Akero Therapeutics
AKRO
$3.5B
$7.86M 0.5%
831,495
– –
RAIN
45
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$6.53M 0.41%
1,175,000
– –
ASND icon
46
Ascendis Pharma
ASND
$12.1B
$6.51M 0.41%
+70,000
New +$6.51M
NGM
47
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$6.41M 0.41%
500,000
– –
CNTA
48
Centessa Pharmaceuticals
CNTA
$2.12B
$6.09M 0.39%
1,251,137
– –
TSVT
49
DELISTED
2seventy bio
TSVT
$6.07M 0.38%
459,836
– –
DBVT
50
DBV Technologies
DBVT
$254M
$5.44M 0.34%
213,460
– –
1
2
3 4